Karyopharm Therapeutics
KPTI
#10476
Rank
C$59.64 M
Marketcap
C$2.63
Share price
5.03%
Change (1 day)
-64.73%
Change (1 year)

Market capitalization of Karyopharm Therapeutics (KPTI)

Market cap: C$59.64 Million

As of September 2026 Karyopharm Therapeutics has a market cap of C$59.64 Million. This makes Karyopharm Therapeutics the world's 10476th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Karyopharm Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026C$59.64 M-65.67%
2025C$0.17 B36.86%
2024C$0.12 B-3.4%
2023C$0.13 B-74.84%
2022C$0.52 B-15.63%
2021C$0.61 B-57.38%
2020C$1.45 B-11.24%
2019C$1.63 B110.8%
2018C$0.77 B36.34%
2017C$0.56 B9.3%
2016C$0.52 B-20.97%
2015C$0.65 B-53.59%
2014C$1.42 B96.76%
2013C$0.72 B

End of Day market cap according to different sources

On Sep 19th, 2026 the market cap of Karyopharm Therapeutics was reported to be:

C$59.64 Million
by Nasdaq info icon info icon
C$59.64 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
C$248.34 B 416,292.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$506.82 B 849,674.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$180.17 B 301,987.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$20.22 B 33,812.18%๐Ÿ‡บ๐Ÿ‡ธ USA